A Phase 1 Study of MKC-1 in Patients With Refractory Hematologic Malignancies

Clinical trial NCT00506402 · COMPLETED

Trial details

NCT number: NCT00506402
Sponsor: CASI pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hematological Malignancies Myelodysplasia Agnogenic Myeloid Metaplasia

Start date: 2006-11-01
Primary completion: 2009-01-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.